Understanding MetLife's underwriting approach for rheumatoid arthritis
MetLife evaluates rheumatoid arthritis (RA) like any other chronic condition: the insurer reviews medical records, disease severity, treatment history, and overall health. Underwriters assign a risk class that influences premiums and eligibility. Well‑controlled RA with minimal joint damage typically receives a standard or preferred rating, while aggressive disease or recent hospitalizations may lead to higher rates or limited coverage.
More from this site
Keep reading the latest coverage
Key factors that influence your application
Several specific elements shape MetLife's decision:
- Diagnosis date and disease duration
- Current activity level (remission, mild, moderate, severe)
- Medications used, especially biologics or immunosuppressants
- Recent flare‑ups, surgeries, or hospital stays
- Comorbid conditions such as cardiovascular disease or osteoporosis
How to prepare your medical documentation
Gathering clear, up‑to‑date records helps the underwriter see the full picture. Include rheumatologist notes that detail disease activity scores, imaging results, and a summary of medication effectiveness. If you have achieved remission or stable disease for at least six months, highlight that stability. Providing lab results that show controlled inflammatory markers (e.g., CRP, ESR) can also be beneficial.
Steps to improve your chances of approval
While you cannot change your diagnosis, you can influence how MetLife views the risk:
- Maintain regular follow‑ups and adhere strictly to prescribed therapy.
- Document any lifestyle changes—exercise, weight management, smoking cessation—that support joint health.
- Ask your doctor for a concise summary that emphasizes disease control and low complication risk.
- Consider a non‑smoker or low‑risk health questionnaire if MetLife offers a simplified issue option.
What to expect after submission
MetLife may request additional information, such as a recent physical exam or clarification on medication side effects. If the initial rating is higher than desired, you can request a review, provide newer test results, or explore alternative MetLife products that have more flexible underwriting for chronic conditions.
Comparing MetLife's stance with other major insurers
| Insurer | Typical RA rating | Notes |
|---|---|---|
| MetLife | Standard to Sub‑Standard | Considers disease control; biologics may raise class. |
| Prudential | Standard to Preferred | Favors applicants in remission. |
| New York Life | Sub‑Standard to Declined | More stringent on recent hospitalizations. |